ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1918

Vigorous Physical Activity in Patients with SLE Was Not Associated with Disease Activity or Socioeconomic and Social Factors

Heather Gold1, Yi Li1, Isabella Giunta1, Jill Buyon1, Peter Izmirly2, Mala Masson3, Amit Saxena1, H Michael Belmont4, Chung-E Tseng5 and Rebecca Anthopolos1, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Health, New York, 4NYU School of Medicine, New York, NY, 5New York University Grossman School of Medicine, Flushing, NY

Meeting: ACR Convergence 2025

Keywords: physical activity, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1914–1935) Health Services Research Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Physical activity can mitigate cardiovascular disease and depression risk and improve fatigue, physical function, and quality of life in patients with SLE. To facilitate physical activity in a diverse patient population with SLE, it is critical to understand whether and how it is associated with socioeconomic, social, demographic, or clinical factors.

Methods: Cross-sectional analysis of patients with SLE from a large, urban city (n=189) who completed the International Physical Activity Questionnaire (IPAQ) based on the past 7-days recall of vigorous physical activity, moderate activity, or walking. Examples of vigorous physical activity include heavy lifting, digging, aerobics, or fast bicycling; moderate activity would include carrying light loads, bicycling at a regular pace, or doubles tennis, but not walking. Variables considered were financial insecurity, Everyday Discrimination Scale, education, age, sex, race, ethnicity, lupus-specific disease activity (any of cutaneous, nephritis, or arthritis), immunosuppressive medication, and Area Deprivation Index. Statistical tests of associations were 2-sided: chi-squared for categorical and Spearman rank correlation for continuous variables. Multivariable analyses applied a quasi-Poisson model due to overdispersion.

Results: The majority of patients (n=120/189, 64%) reported zero days of vigorous physical activity, whereas 42% reported no moderate activity (n=79) and only 4% reported no walking (n=7). Bivariate analyses showed that vigorous physical activity was associated only with lower disease activity (median=0, IQR=0-2 for no vigorous activity vs. median=0, IQR=0-1 for any vigorous activity; p=0.047). Multivariable analysis indicated that the count of vigorous activity days was modestly and negatively associated with disease activity, where a 1-unit increase in disease activity was associated with a 46% decrease in physical activity (p=0.068). Results suggest there is insufficient evidence of significant associations with most covariates in our sample.(Table) Outcomes of total physical activity, moderate activity, and walking in multivariable models showed no significant associations with covariates, leaving only vigorous activity reported here.

Conclusion: The null findings are illuminating and suggest that disease activity and socioeconomic and social factors did not keep patients from engaging in vigorous activity. Future longitudinal analysis will aid in understanding patterns of physical activity related to clinical factors and patient-reported outcome measures of pain, fatigue, depression, and more.

Supporting image 1


Disclosures: H. Gold: None; Y. Li: None; I. Giunta: None; J. Buyon: Artiva Biotherapeutics, 2, Biogen, 2, Bristol-Myers Squibb(BMS), 2, Celgene, 2, CLIMB Bio Operating, 2, GlaxoSmithKlein(GSK), 2, Janssen, 2, Related Sciences, 2, UCB, 2; P. Izmirly: Hansoh Bio, 2; M. Masson: None; A. Saxena: AbbVie/Abbott, 1, Amgen, 1, AstraZeneca, 1, Aurinia, 1, 6, Bristol-Myers Squibb(BMS), 1, GlaxoSmithKlein(GSK), 5, Synthekine, 1, 2, UCB, 1, 6; H. Belmont: None; C. Tseng: None; R. Anthopolos: None.

To cite this abstract in AMA style:

Gold H, Li Y, Giunta I, Buyon J, Izmirly P, Masson M, Saxena A, Belmont H, Tseng C, Anthopolos R. Vigorous Physical Activity in Patients with SLE Was Not Associated with Disease Activity or Socioeconomic and Social Factors [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/vigorous-physical-activity-in-patients-with-sle-was-not-associated-with-disease-activity-or-socioeconomic-and-social-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vigorous-physical-activity-in-patients-with-sle-was-not-associated-with-disease-activity-or-socioeconomic-and-social-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology